Co-Diagnostics, Inc. announced revenue guidance for the first quarter of 2022. For the quarter, the company expected revenue in the range of $21.0 million to $22.0 million.
Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1.3 USD | -9.09% | +24.27% | -1.89% |
05-13 | HC Wainwright Adjusts Price Target on Co-Diagnostics to $2 From $2.50, Maintains Neutral Rating | MT |
05-09 | Transcript : Co-Diagnostics, Inc., Q1 2024 Earnings Call, May 09, 2024 |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-1.89% | 44.73M | |
-27.04% | 16.85B | |
-43.08% | 2.85B | |
+23.56% | 1.96B | |
-12.28% | 1.46B | |
+31.56% | 1.34B | |
-18.43% | 940M | |
+1.55% | 813M | |
-32.96% | 767M | |
-24.93% | 643M |
- Stock Market
- Equities
- CODX Stock
- News Co-Diagnostics, Inc.
- Co-Diagnostics, Inc. Announces Revenue Guidance for the First Quarter of 2022